IHS Markit
18.11.2021 17:55:16 CET | ACCESS Newswire | Press release
Industry leaders join forces to provide combined news distribution and advanced investor and public relations solutions to enhance stakeholder engagement and increase workflow efficiencies for global companies
LONDON, EN and RALEIGH, NC / ACCESSWIRE / November 18, 2021 / IHS Markit (NYSE:INFO), a world leader in critical information, analytics and solutions, and Issuer Direct Corporation (NYSE American:ISDR), an industry-leading communications company, announced that they will collaborate through a strategic alliance to offer a premier suite of Webhosting, Webcasting and News Distribution products.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Under the agreement, IHS Markit and Issuer Direct, whom together serve the world's leading companies, will give IHS Markit the ability to provide customers with access to a comprehensive communications platform of news distribution, web hosting, design, and webcasting to complement an already best-in-class integrated suite of advanced technology, data science and expertise that helps investor relations professionals target shareholders, communicate effectively, evaluate strategy and improve efficiency.
"This collaboration is a natural next step in support of our Investor Relations clients," said Kelly McGeehan, Head of Issuer Solutions at IHS Markit. "We recently announced the launch of IHS Markit's Capital Access, a platform which empowers IR teams to target and engage investors and prospects while measuring and optimizing success. Today's announced partnership with Issuer Direct will enable our clients to communicate results to the market more efficiently. By combining the power of Capital Access with the efficiency generated through this collaboration, we will now be able to support IR teams more fully throughout their IR workflow. We have a robust partnership network, which enables us to provide outstanding service to companies across all market caps, industries, and geographies, and we are pleased to announce this collaboration with Issuer Direct, a best-in-class provider, which further enhances our ability to deliver for clients."
"We are excited to partner with the IHS Markit team to deliver customers our combined suite of premium services. With over 15 years serving Investor Relations and Public Relations professionals, we will be a significant value add to the current top tier IHS Markit offerings". said Jennifer Hammers EVP of Sales and Marketing for Issuer Direct. "The strategic alliance and partnership will give the IHS Markit IRO customer the ability to take advantage of the most comprehensive technology and distribution in a fast-paced communications landscape."
About Issuer Direct:
Issuer Direct is an industry-leading communications company focusing on the needs of Public Relations and Investor Relations Professionals for over 15 years.Offering a comprehensive suite of communications products, Issuer Direct connects thousands of private and public organizations with journalists, investors, and shareholders, ensuring their most important moments are reaching their audiences. Issuer Direct provides the only flat fee news distribution service through its ACCESSWIRE platform, and is a trusted source for online news for investment professionals for over 4000 companies in over 18 countries. For more information, please visit www.issuerdirect.com.
About IHS Markit
IHS Markit (NYSE:INFO) is a world leader in critical information, analytics and solutions for the major industries and markets that drive economies worldwide. The company delivers next-generation information, analytics and solutions to customers in business, finance and government, improving their operational efficiency and providing deep insights that lead to well-informed, confident decisions. IHS Markit has more than 50,000 business and government customers, including 80 percent of the Fortune Global 500 and the world's leading financial institutions. Headquartered in London, IHS Markit is committed to sustainable, profitable growth.
Issuer Direct Corporation Media Contacts:
Brian R. Balbirnie
+1 919-481-4000
brian.balbirnie@issuerdirect.com
James Carbonara
1+ (646)-755-7412
james@haydenir.com
IHS Markit:
Kate Smith
Tel: +1 781 301 9311
katherine.smith@ihsmarkit.com
SOURCE: IHS Markit and Issuer Direct Corp.
View source version on accesswire.com:
https://www.accesswire.com/673145/IHS-Markit-and-Issuer-Direct-Announce-Strategic-Alliance-and-Partnership
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Akkodis Completes the Acquisition of SOGECLAIR's Engineering Activities, Strengthening Its Aerospace & Defense Leadership1.10.2026 17:30:00 CEST | Press release
ZÜRICH, SWITZERLAND / ACCESS Newswire / October 1, 2026 / Akkodis, a global digital engineering consulting company, today announced the completion of its acquisition of SOGECLAIR's engineering activities dedicated to Airbus; SOGECLAIR is a leading international engineering and technology company specializing in aerospace, defense and mobility. Image: Akkodis completes acquisition of SOGECLAIR's engineering activities Source: Akkodis The transaction marks a significant milestone in Akkodis' strategy to strengthen its position in the aerospace and defense sector by expanding its capabilities in aerostructures, cabin engineering and manufacturing engineering. It further enhances Akkodis' ability to support customers across the entire product lifecycle, from design and engineering through industrialization and in-service support. With the integration of SOGECLAIR's engineering activities dedicated to Airbus, Akkodis reinforces its position as one of the leading engineering partners to the
Anew Climate Expands European Forest Carbon Portfolio Through Ten-Year Agreement with Sweden's EKEN1.10.2026 15:00:00 CEST | Press release
HOUSTON, TX / ACCESS Newswire / October 1, 2026 / Anew Climate (Anew), one of the world's largest developers and marketers of carbon credits, announced a ten-year agreement with EKEN Financing Value Added Forestry (EKEN) to bring Swedish improved forest management (IFM) credits to corporate buyers worldwide. The agreement extends Anew's European forest carbon portfolio, which it maintains alongside millions of acres of managed forestland across North America. Under the collaboration, Anew will serve as the exclusive commercialization partner for credits generated from projects developed by EKEN, handling purchaser engagements, structuring, and portfolio integration for corporate buyers in Europe and internationally. EKEN is preparing the project for development under VM0045, Verra's methodology for improved forest management using dynamic matched baselines from national forest inventories. While many conventional forest carbon baselines rest on a projection of what a landowner would hy
Karbon‑X (OTCQB:KARX) Reports Record Fiscal 2026 Revenue of $55.9 Million as Company Scales Global Carbon Market Operations1.10.2026 14:30:00 CEST | Press release
CALGARY, AB / ACCESS Newswire / October 1, 2026 / Karbon‑X Corp. (OTCQB:KARX) ("Karbon‑X" or the "Company"), a vertically integrated climate solutions company operating across global carbon markets, today reported financial and operational results for the fiscal year ended May 31, 2026, reflecting a significant increase in operating scale across its carbon credit trading and project development activities. Karbon‑X generated record fiscal 2026 revenue of $55.9 million, compared with $3.16 million in fiscal 2025, representing an increase of approximately 1,670% year over year. Gross profit was $0.86 million, compared with $0.80 million in the prior year. Fiscal 2026 results reflected a shift in revenue mix toward high-volume, lower-margin trading activity as Karbon‑X completed its first full year of large-scale carbon credit trading. "Fiscal 2026 moved Karbon-X into a new stage of commercial growth," said Chad Clovis, Chief Executive Officer of Karbon-X. "Revenue reached nearly eighteen
Surmodics Acquires Alta Biomed Business, Expanding Hemocompatible Surface Technology and Analytical Testing Capabilities1.10.2026 14:00:00 CEST | Press release
HORSHAM, PA / ACCESS Newswire / October 1, 2026 / Surmodics Inc., a leading provider of surface technologies and performance coatings for the medical device industry, today announced that it has acquired the business of Alta Biomed, a Carlsbad, California-based medical device coating and testing services company specializing in surface technologies for vascular and other medical devices. The acquisition is a strategic addition to Surmodics' growing portfolio of hemocompatible and biocompatible surface technologies. It brings Alta Biomed's proprietary PzF™ thin-film surface modification technology to Surmodics, adding an established anti-thrombotic, anti-inflammatory and pro-healing option that joins Surmodics' existing hemocompatible portfolio. "As medical device innovation advances in neuromodulation, brain-computer interfaces, neurovascular, structural heart, and venous and arterial technologies, engineers and scientists need a broader range of surface technology options to address i
PharmaNest and Mediar Therapeutics Collaborate to Quantify ECM and Fibrosis Remodeling in the EncompaSSc Phase 2 Trial of MTX-474 in Diffuse Cutaneous Systemic Sclerosis30.9.2026 19:00:00 CEST | Press release
PRINCETON, NJ / ACCESS Newswire / September 30, 2026 / PharmaNest, Inc. an AI-enabled digital pathology company specializing in the quantitative and spatial characterization of fibrosis and Mediar Therapeutics, Inc., a clinical-stage biotechnology company pioneering first-in-class therapies to halt and reverse fibrosis, today announced a collaboration to integrate advanced digital pathology into Mediar's ongoing EncompaSSc Phase 2 clinical trial of MTX-474 in patients with diffuse cutaneous systemic sclerosis (dcSSc). MTX-474 is a first-in-class human IgG1 monoclonal antibody designed to neutralize EphrinB2 signaling, a pathway implicated in myofibroblast activation, extracellular matrix (ECM) deposition and tissue remodeling known to drive fibrosis in SSc. The randomized, double-blind, placebo-controlled EncompaSSc Phase 2 study is evaluating the safety and efficacy of MTX-474 in patients with dcSSc. Under the collaboration, PharmaNest will apply its FibroNest™ AI-enabled digital path
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom